Found: 2
Select item for more details and to access through your institution.
Correction to: A Multi-center, Open-Label, Single-Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
A Multi‑Center, Open‑Label, Single‑Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency.
- Published in:
- Journal of Clinical Immunology, 2022, v. 42, n. 3, p. 500, doi. 10.1007/s10875-021-01181-6
- By:
- Publication type:
- Article